Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alon Schaffer
Should Ultrathin Strut Drug Eluting Stents Be Considered the New Benchmark for Novel Coronary Stents Approval? The Complex Interplay Between Stent Strut Thickness, Polymeric Carriers and Antiproliferative Drugs
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Related publications
Ultrathin Strut Biodegradable-Polymer Sirolimus-Eluting Stents: Being Wary or Going With the Flow?
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Biodegradable Polymer Evermine 50™ Everolimus Eluting Coronary Stent System With Ultrathin (50 Μm) Strut
Integrative Clinical Medicine
Drug-Eluting Stents
CMAJ
Medicine
Downstream Coronary Effects of Drug-Eluting Stents
American Heart Journal
Cardiovascular Medicine
Cardiology
Drug-Eluting Stents
CMAJ
Medicine
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation While Enhancing Strut Coverage in Rabbits
PLoS ONE
Multidisciplinary
Should Dual Antiplatelet Therapy After Drug-Eluting Stents Be Continued for More Than 1 Year?: Dual Antiplatelet Therapy After Drug-Eluting Stents Should Be Continued for More Than One Year and Preferably Indefinitely
Circulation: Cardiovascular Interventions
Cardiovascular Medicine
Cardiology
Late Stent Thrombosis in Drug-Eluting Stents: Return of the 'VB Syndrome'
Nature Clinical Practice Cardiovascular Medicine
Steroid-Eluting Stents in Patients With Acute Coronary Syndrome: The Dexamethasone Eluting Stent Italian REgistry
Heart
Cardiovascular Medicine
Cardiology
